Ensaios clínicos de Glioma em Ohio
18 estudos para Glioma estão buscando participantes em locais em Ohio.
Cidades em Ohio
Texto oficial do estudo (Inglês)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Children's Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Rainbow Babies and Childrens Hospital, Cleveland
- e mais 3
RecrutandoFase 1/2
12 Months – 21 Years · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT05099003Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Cleveland Clinic Taussig Cancer Center, Cleveland
- Ohio State University, Columbus
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07326566ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- Cincinnati Children's Hospital, Cincinnati
- Nationwide Children's Hospital, Columbus
RecrutandoFase 2
12 Months – 39 Years · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT06838676Development of MRF for Characterization of Brain Tumors After Radiotherapy
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland
- Cleveland Clinic Taussig Cancer Center, Cleveland
RecrutandoVoluntários saudáveis bem-vindos
Idades de 18 a 60 · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT06101069Targeted Pediatric High-Grade Glioma Therapy
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RecrutandoEstudo observacional
12 Months – 39 Years · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RecrutandoFase 2
Idades de 12 a 39 · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Cleveland Clinic, Cleveland
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de ago. de 2026 · NCT05303519PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RecrutandoFase 2
Idades de 3 a 39 · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT05096481Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 6 de ago. de 2026 · NCT05565118A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Nationwide Children's Hospital, Colombus
- The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
- Taylor Cancer Research Center, Maumee
RecrutandoFase 2
Idades 8 e acima · Todos os sexos · Atualizado em 27 de jul. de 2026 · NCT05503797Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
- Ohio State University Medical Center, Columbus
Recrutando
Idades de 18 a 85 · Todos os sexos · Atualizado em 21 de jul. de 2026 · NCT06910306Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RecrutandoFase 1/2
Idades de 4 a 39 · Todos os sexos · Atualizado em 20 de jul. de 2026 · NCT05278208Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RecrutandoFase 1 inicialVoluntários saudáveis bem-vindos
Idades de 1 a 21 · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT06333899Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RecrutandoFase 2
12 Months – 39 Years · Todos os sexos · Atualizado em 29 de mai. de 2026 · NCT05843253Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas
- Ohio State University Comprehensive Cancer Center, Columbus
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 8 de mai. de 2026 · NCT06964737Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Ohio State University Comprehensive Cancer Center, Columbus
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 13 de abr. de 2026 · NCT06810544A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RecrutandoFase 1 inicial
Até 21 anos · Todos os sexos · Atualizado em 18 de mar. de 2026 · NCT04655404Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells
- Nationwide Children's Hospital, Columbus
RecrutandoFase 1
12 Months – 39 Years · Todos os sexos · Atualizado em 13 de mai. de 2025 · NCT04254419Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.